Single Injection of Bevacizumab Effective in Eyes With Myopic Choroidal Neovascularization
One intravitreal injection of bevacizumab (Avastin,
Genentech) seems to be an effective therapeutic
approach to treat choroidal neovascularization in
highly myopic eyes, according to a study in Retina.1
José M. Ruiz-Moreno, MD, PhD, of the Instituto
Oftalmológico de Alicante, Alicante, Spain, and colleagues
conducte...